[Early reumatoid arthritis]
Clicks: 396
ID: 114357
2018
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
63.9
/100
396 views
278 readers
Trending
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #7 of 18 articles by views in Wiadomosci lekarskie (Warsaw, Poland : 1960)
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Rheumatoid arthritis (RA) is a systemic, autoimmune disease characterized by synovitis and irreversible joint destruction. RA development is a multi-stage process conditioned by the presence of genetic and environmental risk factors on the basis of which systemic immunization develops. The best know …
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (42 words).
Try re-searching for a better abstract.
| Reference Key |
k2018wiadomosci[early
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Kolarz K;Targońska-Stępniak B;Majdan M;; |
| Journal | Wiadomosci lekarskie (Warsaw, Poland : 1960) |
| Year | 2018 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
review
humans
pubmed abstract
nih
national institutes of health
national library of medicine
Bozena Targońska-Stepniak
Maria Majdan
biomarkers / analysis
arthritis
rheumatoid / drug therapy*
rheumatoid / etiology*
rheumatoid / diagnosis*
pmid:30176641
katarzyna kolarz
antirheumatic agents
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.